课题基金 / 基金详情

Melanoma Margins Trial II - A Phase III, Multi-centre Randomized Controlled Trial Investigating 1cm v 2cm Wide Surgical Excision Margins for AJCC stage II Primary Cutaneous Melanoma (MelMarT-II)

Melanoma Margins Trial II - A Phase III, Multi-centre Randomized Controlled Trial Investigating 1cm v 2cm Wide Surgical Excision Margins for AJCC stage II Primary Cutaneous Melanoma (MelMarT-II)
黑色素瘤边缘试验 II - 一项 III 期、多中心随机对照试验，研究 AJCC II 期原发性皮肤黑色素瘤的 1cm v 2cm 宽手术切除边缘 (MelMarT-II)
批准号：
408863
负责人：
Dancey Janet E
金额：
$94.96万
依托单位：
Queen's University (Kingston, Ontario)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2019
资助国家：
加拿大
项目状态：
未结题
起止时间：
2019-09-01 至 2029-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=408863&lang=en
关键词：
Cancer Melanoma Quality Of Life Randomized Controlled Trial Surgery Surgical Morbidity / Complications Wide Local Excision

项目摘要

项目成果

Dancey Janet E的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The incidence of melanoma is increasing worldwide. In 2019, 7800 Canadians will be diagnosed and 1300 will die from melanoma. Wide local excision (WLE) around the primary melanoma and a sentinel lymph node biopsy is standard treatment. The thickness (or d
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Fecal microbiota transplantation in combination with immune checkpoint blockade in patients with advanced melanoma: A randomized phase II trial
海外基金